Last data updates: 06 January 2011
Han, J.S. and Xie, C.W. (1982), Dynorphin - potent analgesic effect in spinal-cord of the rat. Life
Sciences , 31 (16-1), 1781-1784.
Document type: Article Language: English Cited references: 12 Time cited: 97
Times self cited:
12
Reprint Address: Han, JS (reprint author), Beijing Med Coll, Dept Physiol, Beijing 100083, Peoples
R China
1.
Carlezon, W.A., Beguin, C., Knoll, A.T. and Cohen, B.M. (2009), Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacology & Therapeutics , 123 (3), 334-343.
2.
Qu, F. and Zhou, J. (2007), Electro-acupuncture in relieving labor pain. Evidence-Based
Complementary and Alternative Medicine , 4 (1), 125-130.
3.
Mizoguchi, H., Watanabe, H., Hayashi, T., Sakurada, W., Sawai, T., Fujimura, T., Sakurada, T. and Sakurada, S. (2006), Possible involvement of dynorphin A-(1-17) release via mu(1)-opioid receptors in spinal antinociception by endomorphin-2. Journal of Pharmacology and
Experimental Therapeutics , 317 (1), 362-368.
4.
Dong, H.W., Wang, L.H., Zhang, M. and Han, J.S. (2005), Decreased dynorphin A(1-17) in the spinal cord of spastic rats after the compressive injury. Brain Research Bulletin , 67 (3),
189-195.
5.
Han, J.S. (2004), Acupuncture and endorphins. Neuroscience Letters , 361 (1-3), 258-261.
6.
Hallbeck, M., Larhammar, D. and Blomqvist, A. (2001), Neuropeptide expression in rat paraventricular hypothalamic neurons that project to the spinal cord. Journal of Comparative
Neurology , 433 (2), 222-238.
7.
Ballet, S., Mauborgne, A., Hamon, M., Cesselin, F. and Collin, E. (2000), Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats. Synapse , 37 (4), 262-272.
8.
Suh, H.W., Song, D.K., Huh, S.O. and Kim, Y.H. (2000), Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse. Planta
Medica , 66 (5), 412-417.
9.
Hallbeck, M. (2000), Dynorphin mRNA-expressing neurons in the rat paraventricular hypothalamic nucleus project to the spinal cord. Neuroscience Letters , 285 (3), 161-164.
10.
Houser, S.J., Eads, M., Embrey, J.P. and Welch, S.P. (2000), Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. Brain Research , 857 (1-2), 337-342.
11.
Tan-No, K., Taira, A., Inoue, M., Ohshima, K., Sakurada, T., Sakurada, C., Nylander, I.,
Demuth, H.U., Silberring, J., Terenius, L., Tadano, T. and Kisara, K. (1998), Intrathecal administration of p-hydroxymercuribenzoate or phosphoramidon/bestatin-combined induces antinociceptive effects through different opioid mechanisms. Neuropeptides , 32 (5), 411-415.

12.
Hu, W.H., Zhang, C.H., Yang, H.F., Zheng, Y.F., Liu, N., Sun, X.J., Jen, J. and Jen, M.F.
(1998), Mechanism of the dynorphin-induced dualistic effect on free intracellular Ca 2+ concentration in cultured rat spinal neurons. European Journal of Pharmacology , 342 (2-3),
325-332.
13.
Pugh, G., Mason, D.J., Combs, V. and Welch, S.P. (1997), Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord. Journal of
Pharmacology and Experimental Therapeutics , 281 (2), 730-737.
14.
Laurido, C., Hernandez, A. and Perez, H. (1996), Cross-tolerance to acute administration of
MU and kappa opioid agonists at the spinal cord level in the rat. International Journal of
Neuroscience , 87 (3-4), 191-199.
15.
Chen, X.H., LiuChen, L.Y., Tallarida, R.J., Geller, E.B., deRiel, J.K. and Adler, M.W. (1996),
Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo. Neurochemical Research , 21 (11), 1363-1368.
16.
Tanno, K., Taira, A., Sakurada, T., Inoue, M., Sakurada, S., Nylander, I., Silberring, J., Tadano,
T., Sato, T., Sakurada, C., Terenius, L. and Kisara, K. (1996), Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test. European Journal of Pharmacology , 314
(1-2), 61-67.
17.
DawsonBasoa, M.E. and Gintzler, A.R. (1996), Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms (vol 64, pg 169, 1996). Pain , 64 (3), 607-615.
18.
Chen, X.H., Geller, E.B. and Adler, M.W. (1996), Electrical stimulation at traditional acupuncture sites in periphery produces brain opioid-receptor-mediated antinociception in rats.
Journal of Pharmacology and Experimental Therapeutics , 277 (2), 654-660.
19.
DawsonBasoa, M.E. and Gintzler, A.R. (1996), Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms. Pain , 64 (1), 169-177.
20.
Gogas, K.R., Levine, J.D. and Basbaum, A.I. (1996), Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids, an analysis of formalin-evoked c-fos expression. Journal of Pharmacology and Experimental Therapeutics ,
276 (2), 801-809.
21.
Xue, J.C., Yu, Y.X., Han, J.S. and Jen, M.F. (1995), Comparative-Study of the Analgesic and
Paralytic Effects Induced by Intrathecal Dynorphin-A in Rats. International Journal of
Neuroscience , 82 (1-2), 83-93.
22.
Xue, J.C., Yu, Y.X., Han, J.S. and Jen, M.F. (1995), Changes in the Content of
Immunoreactive Dynorphin in Dorsal and Ventral Spinal-Cord of the Rat in 3 Different
Conditions. International Journal of Neuroscience , 82 (1-2), 95-104.
23.
Stanfa, L. and Dickenson, A. (1995), Spinal Opioid Systems in Inflammation. Inflammation
Research , 44 (6), 231-241.
24.
Mcintosh, T.K., Fernyak, S., Yamakami, I. and Faden, A.I. (1994), Central and Systemic
Kappa-Opioid Agonists Exacerbate Neurobehavioral Response to Brain Injury in Rats.
American Journal of Physiology , 267 (3), R665-R672.

25.
Yuan, Y., Yan, S.C., Chen, X.H. and Han, J.S. (1994), 66A-078-A Kappa-Opiate Receptor
Agonist for Amelioration of Spinal Spasticity. Chinese Medical Journal , 107 (3), 192-195.
26.
Aceto, M.D. and Bowman, E.R. (1992), Blockade of Dynorphin-A(1-13) Overt Psychomotor
Effects by Naloxone. Peptides , 13 (4), 847-849.
27.
Bakshi, R., Ni, R.X. and Faden, A.I. (1992), N-Methyl-D-Aspartate (Nmda) and Opioid
Receptors Mediate Dynorphin-Induced Spinal-Cord Injury - Behavioral and Histological
Studies. Brain Research , 580 (1-2), 255-264.
28.
Chen, X.H. and Han, J.S. (1992), Analgesia Induced by Electroacupuncture of Different
Frequencies Is Mediated by Different Types of Opioid Receptors - Another Cross-Tolerance
Study. Behavioural Brain Research , 47 (2), 143-149.
29.
Hammond, D.L., Presley, R., Gogas, K.R. and Basbaum, A.I. (1992), Morphine Or U-50,488
Suppresses Fos Protein-Like Immunoreactivity in the Spinal-Cord and
Nucleus-Tractus-Solitarii Evoked by A Noxious Visceral Stimulus in the Rat. Journal of
Comparative Neurology , 315 (2), 244-253.
30.
Klein, C.M., Sorkin, L.S., Chung, K. and Coggeshall, R.E. (1991), Unmyelinated Primary
Afferent Fiber Stimulation Depletes Dynorphin-A (1-8) Immunoreactivity in Rat Ventral Horn.
Brain Research , 566 (1-2), 70-76.
31.
Ren, K., Randich, A. and Gebhart, G.F. (1991), Spinal Serotonergic and Kappa Opioid
Receptors Mediate Facilitation of the Tail Flick Reflex Produced by Vagal Afferent
Stimulation. Pain , 45 (3), 321-329.
32.
Gogas, K.R., Presley, R.W., Levine, J.D. and Basbaum, A.I. (1991), The Antinociceptive
Action of Supraspinal Opioids Results from An Increase in Descending Inhibitory Control -
Correlation of Nociceptive Behavior and C-Fos Expression. Neuroscience , 42 (3), 617-628.
33.
Herman, B.H. (1990), A Possible Role of Proopiomelanocortin Peptides in
Self-Injurious-Behavior. Progress in Neuro-Psychopharmacology & Biological Psychiatry , 14 ,
S109-S139.
34.
Sullivan, A.F. and Dickenson, A.H. (1991), Electrophysiologic Studies on the Spinal
Antinociceptive Action of Kappa-Opioid Agonists in the Adult and 21-Day-Old Rat. Journal of Pharmacology and Experimental Therapeutics , 256 (3), 1119-1125.
35.
Song, Z.H. and Takemori, A.E. (1991), Involvement of Spinal Kappa-Opioid Receptors in the
Antagonistic Effect of Dynorphins on Morphine Antinociception. Life Sciences , 48 (15),
1447-1453.
36.
Spampinato, S. and Ferri, S. (1991), Pharmacology of Spinal Peptides Affecting Sensory and
Motor Functions - Dynorphins, Somatostatins and Tachykinins. Pharmacological Research ,
23 (2), 113-127.
37.
Yirmiya, R., Beneliyahu, S., Shavit, Y., Marek, P. and Liebeskind, J.C. (1990), Stimulation of the Hypothalamic Paraventricular Nucleus Produces Analgesia Not Mediated by Vasopressin
Or Endogenous Opioids. Brain Research , 537 (1-2), 169-174.

38.
Bakshi, R., Newman, A.H. and Faden, A.I. (1990), Dynorphin-A-(1-17) Induces Alterations in
Free Fatty-Acids, Excitatory Amino-Acids, and Motor Function Through An
Opiate-Receptor-Mediated Mechanism. Journal of Neuroscience , 10 (12), 3793-3800.
39.
Przewlocka, B., Lason, W. and Dziedzicka, M. (1990), Modulation of Prodynorphin Peptides
Release from the Rat Spinal-Cord Invitro. Neuropeptides , 16 (4), 201-206.
40.
Wang, Q., Mao, L.M. and Han, J.S. (1990), Diencephalon As A Cardinal Neural Structure for
Mediating 2 Hz-Electroacupuncture-Induced But Not 100 Hz-Electroacupuncture-Induced Tail
Flick Reflex Suppression. Behavioural Brain Research , 37 (2), 149-156.
41.
Tiseo, P.J., Adler, M.W. and Liuchen, L.Y. (1990), Differential Release of Substance-P and
Somatostatin in the Rat Spinal-Cord in Response to Noxious Cold and Heat - Effect of
Dynorphin A(1-17). Journal of Pharmacology and Experimental Therapeutics , 252 (2),
539-545.
42.
Wood, M.S., Rodriguez, F.D. and Traynor, J.R. (1989), Characterization of K-Opioid
Binding-Sites in Rat and Guinea-Pig Spinal-Cord. Neuropharmacology , 28 (10), 1041-1046.
43.
Takahashi, M., Tokuyama, S. and Kaneto, H. (1989), Release of Substance-P by Intrathecal
Kk-3, A Newly Synthesized Leu-Enkephalin Derivative. Pharmacology Biochemistry and
Behavior , 33 (4), 843-846.
44.
Parsons, C.G. and Headley, P.M. (1989), Spinal Antinociceptive Actions of Mu-Opioids and
Kappa-Opioids - the Importance of Stimulus-Intensity in Determining Selectivity Between
Reflexes to Different Modalities of Noxious Stimulus. British Journal of Pharmacology , 98
(2), 523-532.
45.
Silberring, J. and Nyberg, F. (1989), A Novel Bovine Spinal-Cord Endoprotease with High
Specificity for Dynorphin-B. Journal of Biological Chemistry , 264 (19), 11082-11086.
46.
Przewlocka, B., Vetulani, J., Lason, W., Dziedzicka, M., Silberring, J., Castellano, C. and
Przewlocki, R. (1988), The Difference in Stress-Induced Analgesia in C57Bl/6 and Dba/2
Mice - A Search for Biochemical Correlates. Polish Journal of Pharmacology and Pharmacy ,
40 (5), 497-506.
47.
Cho, H.J. and Basbaum, A.I. (1989), Ultrastructural Analysis of Dynorphin B-Immunoreactive
Cells and Terminals in the Superficial Dorsal Horn of the Deafferented Spinal-Cord of the Rat.
Journal of Comparative Neurology , 281 (2), 193-205.
48.
Long, J.B., Mobley, W.C. and Holaday, J.W. (1988), Neurological Dysfunction After
Intrathecal Injection of Dynorphin-A (1-13) in the Rat .1. Injection Procedures Modify
Pharmacological Responses. Journal of Pharmacology and Experimental Therapeutics , 246
(3), 1158-1166.
49.
Long, J.B., Petras, J.M., Mobley, W.C. and Holaday, J.W. (1988), Neurological Dysfunction
After Intrathecal Injection of Dynorphin-A (1-13) in the Rat .2. Nonopioid Mechanisms
Mediate Loss of Motor, Sensory and Autonomic Function. Journal of Pharmacology and
Experimental Therapeutics , 246 (3), 1167-1174.
50.
Przewlocki, R. (1987), Opioid-Peptides in Relation to Antinociception. Polish Journal of
Pharmacology and Pharmacy , 39 (5), 609-621.

51.
Tiseo, P.J., Geller, E.B. and Adler, M.W. (1988), Antinociceptive Action of
Intracerebroventricularly Administered Dynorphin and Other Opioid-Peptides in the Rat.
Journal of Pharmacology and Experimental Therapeutics , 246 (2), 449-453.
52.
Fleetwoodwalker, S.M., Hope, P.J., Mitchell, R., Elyassir, N. and Molony, V. (1988), The
Influence of Opioid Receptor Subtypes on the Processing of Nociceptive Inputs in the Spinal
Dorsal Horn of the Cat. Brain Research , 451 (1-2), 213-226.
53.
Sakurada, T., Takahashi, K., Sakurada, S., Kisara, K., Folkesson, R. and Terenius, L. (1988),
Enkephalins Interact with Substance-P-Induced Aversive Behavior in Mice. Brain Research ,
442 (1), 191-194.
54.
Nahin, R.L. (1987), Immunocytochemical Identification of Long Ascending Peptidergic
Neurons Contributing to the Spinoreticular Tract in the Rat. Neuroscience , 23 (3), 859-869.
55.
Long, J.B., Kinney, R.C., Malcolm, D.S., Graeber, G.M. and Holaday, J.W. (1987), Intrathecal
Dynorphin A1-13 and Dynorphin A3-13 Reduce Rat Spinal-Cord Blood-Flow by Non-Opioid
Mechanisms. Brain Research , 436 (2), 374-379.
56.
Caudle, R.M. and Isaac, L. (1987), Intrathecal Dynorphin(1-13) Results in An Irreversible
Loss of the Tail-Flick Reflex in Rats. Brain Research , 435 (1-2), 1-6.
57.
Knox, R.J. and Dickenson, A.H. (1987), Effects of Selective and Nonselective Chi-Opioid
Receptor Agonists on Cutaneous-C-Fiber-Evoked Responses of Rat Dorsal Horn Neurons.
Brain Research , 415 (1), 21-29.
58.
Stevens, C.W., Weinger, M.B. and Yaksh, T.L. (1987), Intrathecal Dynorphins Suppress
Hindlimb Electromyographic Activity in Rats. European Journal of Pharmacology , 138 (2),
299-302.
59.
Przewlocki, R., Lason, W., Hollt, V., Silberring, J. and Herz, A. (1987), The Influence of
Chronic Stress on Multiple Opioid Peptide Systems in the Rat - Pronounced Effects Upon
Dynorphin in Spinal-Cord. Brain Research , 413 (2), 213-219.
60.
Schmauss, C. (1987), Spinal Kappa-Opioid Receptor-Mediated Antinociception Is
Stimulus-Specific. European Journal of Pharmacology , 137 (2-3), 197-205.
61.
Marks, N., Berg, M.J., Benuck, M., Lo, E.S., Novachenko, H. and Seyfried, C.A. (1987),
Prodynorphin Processing by Rat Cns Fractions and Purified Enzymes - Formation of
Dynorphin A 1-8 by Sulfhydryl-Activated Carboxypeptidase and Peptidyl Dipeptidase.
Neurochemistry International , 10 (4), 413-422.
62.
Dickenson, A.H. and Knox, R.J. (1987), Antagonism of Mu-Opioid Receptor-Mediated
Inhibitions of Nociceptive Neurons by U50488H and Dynorphin A1-13 in the Rat Dorsal Horn.
Neuroscience Letters , 75 (2), 229-234.
63.
Millan, M.J. (1986), Multiple Opioid Systems and Pain. Pain , 27 (3), 303-347.
64.
Cesselin, F. (1986), Endomorphins and Nociception. Revue Neurologique , 142 (8-9), 649-670.
65.
Stevens, C.W. and Yaksh, T.L. (1986), Dynorphin-A and Related Peptides Administered
Intrathecally in the Rat - A Search for Putative Kappa-Opiate Receptor Activity. Journal of
Pharmacology and Experimental Therapeutics , 238 (3), 833-838.

66.
Gouarderes, C., Kopp, N., Cros, J. and Quirion, R. (1986), Kappa Opioid Receptors in Human
Lumbosacral Spinal-Cord. Brain Research Bulletin , 16 (3), 355-361.
67.
Xie, C.W., Tang, J. and Han, J.S. (1986), Clonidine Stimulated the Release of Dynorphin in the Spinal-Cord of the Rat - A Possible Mechanism for Its Depressor Effects. Neuroscience
Letters , 65 (2), 224-228.
68.
Jhamandas, K., Sutak, M. and Lemaire, S. (1986), Comparative Spinal Analgesic Action of
Dynorphin1-8, Dynorphin1-13, and A Kappa-Receptor Agonist U50,488. Canadian Journal of
Physiology and Pharmacology , 64 (3), 263-268.
69.
Basbaum, A.I., Cruz, L. and Weber, E. (1986), Immunoreactive Dynorphin-B in Sacral
Primary Afferent-Fibers of the Cat. Journal of Neuroscience , 6 (1), 127-133.
70.
Ren, M.F., Lu, C.H. and Han, J.S. (1985), Dynorphin-A-(1-13) Antagonizes Morphine
Analgesia in the Brain and Potentiates Morphine Analgesia in the Spinal-Cord. Peptides , 6 (6),
1015-1020.
71.
Basbaum, A.I. (1985), Functional-Analysis of the Cyto-Chemistry of the Spinal Dorsal Horn.
Advances in Pain Research and Therapy , 9 , 149-175.
72.
Panerai, A.E., Sacerdote, P., Spampinato, S., Candeletti, S., Ferri, S. and Mantegazza, P.
(1985), Naloxone-Reversible and Non-Reversible Shock-Induced Analgesia During
Development. Neuroscience Letters , 60 (3), 247-253.
73.
Cruz, L. and Basbaum, A.I. (1985), Multiple Opioid-Peptides and the Modulation of Pain -
Immunohistochemical Analysis of Dynorphin and Enkephalin in the Trigeminal Nucleus
Caudalis and Spinal-Cord of the Cat. Journal of Comparative Neurology , 240 (4), 331-348.
74.
Wen, H.L., Mehal, Z.D., Ong, B.H., Ho, W.K.K. and Wen, D.Y.K. (1985), Intrathecal
Administration of Beta-Endorphin and Dynorphin-(1-13) for the Treatment of Intractable Pain.
Life Sciences , 37 (13), 1213-1220.
75.
Urca, G. and Nofreshef, A. (1985), Spinal Mechanisms of the Analgesic Action of
Electroconvulsive Shock. Brain Research , 341 (1), 110-118.
76.
Gouarderes, C., Cros, J. and Quirion, R. (1985), Autoradiographic Localization of Mu-Opioid,
Delta-Opioid and Kappa-Opioid Receptor-Binding Sites in Rat and Guinea-Pig Spinal-Cord.
Neuropeptides , 6 (4), 331-342.
77.
Shearman, G.T., Schulz, R., Schiller, P.W. and Herz, A. (1985), Generalization Tests with
Intraventricularly Applied Pro-Enkephalin B-Derived Peptides in Rats Trained to Discriminate the Opioid Kappa Receptor Agonist Ethylketocyclazocine. Psychopharmacology , 85 (4),
440-443.
78.
Villanueva, L., Cadden, S., Chitour, D. and Lebars, D. (1985), Failure of Es-52, A Highly
Potent Enkephalinase Inhibitor, to Affect Nociceptive Transmission by Rat Dorsal Horn
Convergent Neurons. Brain Research , 333 (1), 156-160.
79.
Spampinato, S. and Candeletti, S. (1985), Characterization of Dynorphin-A-Induced
Antinociception at Spinal Level. European Journal of Pharmacology , 110 (1), 21-30.

80.
Kosterlitz, H.W. and Paterson, S.J. (1985), Types of Opioid Receptors - Relation to
Antinociception. Philosophical Transactions of the Royal Society of London Series
B-Biological Sciences , 308 (1136), 291-297.
81.
Hollt, V., Sanchezblazquez, P. and Garzon, J. (1985), Multiple Opioid Ligands and Receptors in the Control of Nociception. Philosophical Transactions of the Royal Society of London
Series B-Biological Sciences , 308 (1136), 299-310.
82.
Quirion, R. (1984), Pain, Nociception and Spinal Opioid Receptors. Progress in
Neuro-Psychopharmacology & Biological Psychiatry , 8 (4-6), 571-579.
83.
Xie, G.X. and Han, J.S. (1984), Dynorphin - Analgesic Effect Via Kappa Receptors in
Spinal-Cord of Rats. Acta Pharmacologica Sinica , 5 (4), 231-234.
84.
Herman, B.H. and Goldstein, A. (1985), Antinociception and Paralysis Induced by Intrathecal
Dynorphin-A. Journal of Pharmacology and Experimental Therapeutics , 232 (1), 27-32.
85.
Herz, A. (1984), Role of Multiple Opioid Receptors and Corresponding Ligands in Pain
Modulation. Arzneimittel-Forschung/Drug Research , 34-2 (9A), 1080-1083.
86.
Panerai, A.E., Martini, A., Sacerdote, P. and Mantegazza, P. (1984), Chi-Receptor Antagonist
Reverse Non-Opioid Stress-Induced Analgesia. Brain Research , 304 (1), 153-156.
87.
Berg, M.J. and Marks, N. (1984), Formation of Des-Tyr Dynorphins-5-17 by A Purified
Cytosolic Aminopeptidase of Rat-Brain. Journal of Neuroscience Research , 11 (3), 313-321.
88.
Wen, H.L., Ho, W.K.K. and Wen, P.Y.C. (1984), Comparison of the Effectiveness of Different
Opioid-Peptides in Suppressing Heroin Withdrawal. European Journal of Pharmacology , 100
(2), 155-162.
89.
Han, J.S. and Xie, G.X. (1984), Dynorphin - Important Mediator for Electroacupuncture
Analgesia in the Spinal-Cord of the Rabbit. Pain , 18 (4), 367-376.
90.
Lee, N.M. and Smith, A.P. (1984), Possible Regulatory Function of Dynorphin and Its Clinical
Implications. Trends in Pharmacological Sciences , 5 (3), 108-110.
91.
Han, J.S., Xie, G.X. and Goldstein, A. (1984), Analgesia Induced by Intrathecal Injection of
Dynorphin-B in the Rat. Life Sciences , 34 (16), 1573-1579.
92.
Basbaum, A.I. and Fields, H.L. (1984), Endogenous Pain Control-Systems - Brain-Stem Spinal
Pathways and Endorphin Circuitry. Annual Review of Neuroscience , 7 , 309-338.
93.
Beaumont, A. (1983), Putative Peptide Neurotransmitters - the Opioid-Peptides. International
Review of Experimental Pathology , 25 , 279-305.
94.
Kaneto, H. (1983), Gifts of Heaven - Opium and Opioid-Peptides. Trends in Pharmacological
Sciences , 4 (11), 475-477.
95.
Calthrop, J. and Hill, R.G. (1983), The Action of Kappa-Agonists on the Nociceptive
Responses of Neurons in the Medullary Dorsal Horn of the Anesthetized Rat. Life Sciences , 33 ,
541-544.
96.
Kaneko, T., Nakazawa, T., Ikeda, M., Yamatsu, K., Iwama, T., Wada, T., Satoh, M. and
Takagi, H. (1983), Sites of Analgesic Action of Dynorphin. Life Sciences , 33 , 661-664.

97.
Przewlocki, R., Shearman, G.T. and Herz, A. (1983), Mixed Opioid Nonopioid Effects of
Dynorphin and Dynorphin Related Peptides After Their Intrathecal Injection in Rats.
Neuropeptides , 3 (3), 233-240.